Drug application
BRICANYL (TERBUTALINE SULFATE)
Drugs@FDA NDA 017466 · SANOFI AVENTIS US
Key facts
| Drug name | BRICANYL |
|---|---|
| Active ingredients | TERBUTALINE SULFATE |
| Application type | NDA |
| Application number | 017466 |
| Company | SANOFI AVENTIS US |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 1MG/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Mar 25, 1974 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.